v3.26.3
Business Segment - Summary of Segment Reporting Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]              
Total revenues $ 9     $ 26   $ 67 $ 214
Adjusted for expense (income):              
Non-operating income, net (3)     (7)   (14) (25)
Net loss (128) $ (91) $ (128) (135) $ (112) (347) (247)
Reportable segment              
Segment Reporting [Line Items]              
Total revenues 9     26   67 214
Adjusted for expense (income):              
Late-stage development programs 54     78   165 207
Early-stage development and preclinical programs 17     33   56 113
Compensation and personnel costs 59     59   187 187
Depreciation and amortization 2     2   7 7
Partnership reimbursements (12)     (28)   (48) (99)
Other segment items 20     24   61 71
Non-operating income, net (3)     (7)   (14) (25)
Net loss $ (128)     $ (135)   $ (347) $ (247)